From the press release associated with [4];
The new research, in mice, demonstrates that eliminating the protein – called orexin – made mice sleep for longer periods of time and strongly slowed the production of brain plaques.
“This indicates we should be looking hard at orexin as a potential target for preventing Alzheimer’s disease,” said senior author David M. Holtzman, MD, head of the Department of Neurology. “Blocking orexin to increase sleep in patients with sleep abnormalities, or perhaps even to improve sleep efficiency in healthy people, may be a way to reduce the risk of Alzheimer’s. This is important to explore further.” - [5]
[1] Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., … Nedergaard, M. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342(6156), 373–377. http://www.sciencemag.org/content/342/6156/373
[2] Ju, Y.-E. S., McLeland, J. S., Toedebusch, C. D., Xiong, C., Fagan, A. M., Duntley, S. P., … Holtzman, D. M. (2013). Sleep quality and preclinical Alzheimer disease. JAMA Neurology, 70(5), 587–593. http://www.ncbi.nlm.nih.gov/pubmed/23479184
[3] Ju, Y.-E. S., Lucey, B. P., & Holtzman, D. M. (2013). Sleep and Alzheimer disease pathology - a bidirectional relationship. Nature Reviews. Neurology, 10(2), 115–119. http://www.nature.com/nrneurol/journal/v10/n2/abs/nrneurol.2...
[4] Roh, J. H., Jiang, H., Finn, M. B., Stewart, F. R., Mahan, T. E., Cirrito, J. R., … Holtzman, D. M. (2014). Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease. The Journal of Experimental Medicine, 211(13), 2487–2496. http://jem.rupress.org/content/211/13/2487